Dr. Crawford is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 North Caroline Street
Baltimore, MD 21287Phone+1 410-955-4259Fax+1 410-367-2767
Education & Training
- Johns Hopkins UniversityFellowship, Neuromuscular Medicine (Neurology), 1987 - 1988
- Children's Hospital Los AngelesResidency, Child Neurology, 1985 - 1987
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Neurology, 1984 - 1985
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pediatrics, 1980 - 1984
- Keck School of Medicine of the University of Southern CaliforniaClass of 1980
- Yale CollegeBA, Psychology and Religion, 1972 - 1976
Certifications & Licensure
- CA State Medical License 1981 - Present
- MD State Medical License 1988 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Awards, Honors, & Recognition
- Member Miller Coulson Academy, 2018
- America's Top Doctors Castle Connolly, 2002-2014
- A.B. Baker Teacher Recognition Certificate American Academy of Neurology, 2013
- Join now to see all
Clinical Trials
- CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I Start of enrollment: 2008 Apr 01
- A Pilot Study of Biomarkers for Spinal Muscular Atrophy Start of enrollment: 2008 Oct 01
- An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy Start of enrollment: 2012 Oct 31
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsRecurrent pneumothoraces associated with nocturnal noninvasive ventilation in a patient with muscular dystrophy.Lee R. Choo-Kang, Folasade O. Ogunlesi, Sharon A. McGrath-Morrow, Thomas O. Crawford, Carole L. Marcus
Pediatric Pulmonology. 2002-07-01 - 61 citationsAnti-myelin-associated glycoprotein antibodies alter neurofilament spacingMichael P. Lunn, Thomas O. Crawford, Richard A. C. Hughes, John W. Griffin, Kazim A. Sheikh
Brain. 2002-04-01 - 297 citationsAntibody-mediated clearance of alphavirus infection from neurons.Beth Levine, J. Marie Hardwick, Bruce D. Trapp, Thomas O. Crawford, Robert C. Bollinger
Science. 1991-11-08
Journal Articles
- High-dose glucocorticoid therapy in the management of seizures in neontatal incontinentia pigmenti: A case reportWolf DS, Golden WC, Hoover-Fong J, Applegate C, Cohen BA, Germain-Lee EL, Goldberg MF, Crawford TO, Gauda EB, J Child Neurol, 1/1/2014
- Susceptibility-weighted imaging in Cockayne syndromeWagner MW, Poretti A, Wang T, Crawford TO, Huisman TAGM, Bosemani T, J Pediatr, 1/1/2014
- Cerebral abnormalities in adults with ataxia telangiectasiaLin DDM, Barker PB, Lederman HM, Crawford TO, Am J Neuroradiol, 1/1/2014
- Join now to see all
Books/Book Chapters
Lectures
- What is Static, What is Degenerative and how can we measure each?7/1/2013
- Challenges in Drug Discovery for Ataxia Telangiectasia11/1/2012
- Instrumented and non-instrumented assessments6/1/2012
- Join now to see all
Press Mentions
- New Data Reaffirm Clinically Meaningful Benefit of SPINRAZAJune 29th, 2017
- Fewer Side Effects, but at What Cost?February 16th, 2017
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/thomas-crawford
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: